SION Q3 2025 Earnings — Sionna Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SIONSionna Therapeutics, Inc.

$2B

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$100,000

Operating Income

-$24M

Net Income

-$20M

EPS (Diluted)

$-0.46

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$339M

Total Liabilities

$18M

Stockholders' Equity

$322M

Cash & Equivalents

$51M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$100,000	$0	—
Operating Income	-$24M	-$28M	+14.9%
Net Income	-$20M	-$25M	+20.3%